Osenvelt 120 MG per 1.7 ML Injection

RxCUI: 2717873
RxNorm name: Osenvelt 120 MG per 1.7 ML Injection
Display name: Osenvelt 120 MG per 1.7 ML Injection
Full name: Osenvelt 120 MG per 1.7 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761404	Stoboclo	denosumab-bmwo	351(k) Interchangeable	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Osenvelt	DENOSUMAB-BMWO	CELLTRION USA, Inc.	c5a5d750-80be-49cd-b4a6-c8a815956059	2026-02-05	Warnings, Adverse reactions	Exact identifier rxcui: 2717873

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c5a5d750-80be-49cd-b4a6-c8a815956059	Osenvelt 120 MG per 1.7 ML Injection	SY	7	These highlights do not include all the information needed to use OSENVELT safely and effectively. See full prescribing information for OSENVELT. OSENVELT ® (denosumab-bmwo) injection, for subcutaneous use Initial U.S. Approval: 2025 OSENVELT ® (denosumab-bmwo) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20260205
c5a5d750-80be-49cd-b4a6-c8a815956059	1.7 ML denosumab-bmwo 70 MG/ML Injection [Osenvelt]	SBD	7	These highlights do not include all the information needed to use OSENVELT safely and effectively. See full prescribing information for OSENVELT. OSENVELT ® (denosumab-bmwo) injection, for subcutaneous use Initial U.S. Approval: 2025 OSENVELT ® (denosumab-bmwo) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20260205
c5a5d750-80be-49cd-b4a6-c8a815956059	Osenvelt 120 MG in 1.7 ML Injection	PSN	7	These highlights do not include all the information needed to use OSENVELT safely and effectively. See full prescribing information for OSENVELT. OSENVELT ® (denosumab-bmwo) injection, for subcutaneous use Initial U.S. Approval: 2025 OSENVELT ® (denosumab-bmwo) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20260205
c5a5d750-80be-49cd-b4a6-c8a815956059	1.7 ML Osenvelt 70 MG/ML Injection	SY	7	These highlights do not include all the information needed to use OSENVELT safely and effectively. See full prescribing information for OSENVELT. OSENVELT ® (denosumab-bmwo) injection, for subcutaneous use Initial U.S. Approval: 2025 OSENVELT ® (denosumab-bmwo) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20260205